WHO releases global vaccine market report 2024

The WHO has released the Global Vaccine Market Report 2024, providing a snapshot of vaccine markets globally in 2023, covering 88 vaccine products sold in 207 countries and procurement channels by 116 manufacturers.  The report analyses market trends between different country income groups and regions and over time using historical data, to support an improved understanding of individual vaccine markets as well as cross-cutting issues. The insights from this report provide valuable market intelligence to governments, industry, global public health agencies, and other key decision-makers. It helps identify challenges and opportunities to accelerate equitable access to vaccines worldwide, aligning with the Call to Action issued in the 2022 Global Vaccine Market Report, which remains highly relevant today.

Key takeaways on procurement and pricing

• Self-procuring middle-income countries (MICs) represented approximately 40% of market volumes, followed by pooled procurement initiatives (UNICEF and PAHO), which represented 36% of globally procured volumes in 2023 with self-procuring high-income countries (HICs) accounting for the remaining 24% of the volumes. From a financial value perspective, HICs continue to dominate with 72% of the financial value, up from 65% in 2022, while MICs account for 24% and pooled procurement accounts for the remaining 4% of the financial value.
• Globally, vaccine prices have remained relatively stable in the last years. Vaccine prices within individual markets tend to be tiered across countries based on their income group, similar to previous years. Likewise, prices paid by self-procuring countries exhibited greater variability than prices paid by countries who used pooled procurement mechanisms, underlining the importance of UNICEF Supply Division for Gavi supported countries and PAHO Revolving Fund for access to vaccines for self-financing countries.